Global Research Services has entered into a strategic alliance with CardioDynamics. The agreement authorizes GRS to utilize CardioDynamics's impedance cardiography technology for advanced processing of noninvasive hemodynamic ICG data.
Subscribe to our email newsletter
CardioDynamics’s impedance cardiography (ICG) products enable Global Research Services (GRS) to provide expanded biometrics and data management services in support of clinical trials. The combined strengths of both the companies will allow biotechnology, pharmaceutical, and device companies and clinical research sites to obtain the benefits of enhanced cardiac safety monitoring in Phase I through IV clinical trials.
Sandra Garrett, executive chair, GRS, said: “This technology, coupled with our Oracle Clinical data management capabilities clearly elevates the capability of cardiac safety monitoring and evaluation in research settings.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.